Overweight and Obesity in Pediatric Crohn Disease Increases Risk for Adalimumab Treatment Failure
Clinical Advisor,
Children and adolescents with Crohn disease with a high body mass index may require a higher dose of adalimumab.
High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn’s Disease
Overview of attention for article published in American Journal of Gastroenterology, March 2024
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (91st percentile)
-
Good Attention Score compared to outputs of the same age and source (65th percentile)
Readers on
- mendeley
- 36 Mendeley
